Position in RGNX
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$2,027,962
-$6,189,558 QoQ
Shares Held
169,279
-82.7% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 164 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. RGNX ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in RGNX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,027,962 | 169,279 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $8,217,520 | 980,611 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $16,709,472 | 1,160,380 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $6,807,138 | 705,403 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $4,699,904 | 572,461 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $4,098,186 | 573,173 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $6,621,301 | 856,572 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,873,057 | 559,872 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $9,551,692 | 816,384 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,795,763 | 227,611 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,914,941 | 106,682 | Shares | Sole | 2024-01-17 | |
| 2022-06-30 | $8,969,508 | 363,138 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $12,052,550 | 363,138 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $9,080,790 | 277,700 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,774,605 | 137,753 | Shares | Sole | 2021-10-19 | |
| 2020-06-30 | $1,704,934 | 46,292 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,185,390 | 67,492 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||